Foresite Capital Fund VI LP
Late investment period
Late investment period: first sale Jul 2022, per Form D (fund age approximates vintage)
- Vintage
- 2022
- Fund size
- $551.1M to $722.85M (Form D and SEC adviser filing)
- Stages
- Pre-seed, Seed, Series A, Series B, Growth
- Sectors
- Biotech, Healthtech
- Regions
- Not stated
01 · Thesis
Foresite Capital is a multi-stage healthcare and life sciences investor. It backs companies that leverage biology and big data, focusing on the intersection of tech and biotech, from incubation through IPO.Inferred from the firm's website
02 · Initial check
$3.67M to $9.04M (estimated from fund size)
Estimated from Form D and SEC adviser filing
03 · Who to approach
Named on this fund's Form D
- Jim Tananbaum, Founder & CEO
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideForesite Capital is a multi-stage healthcare and life sciences investment firm addressing areas of great unmet need by funding promising businesses at all stages of their life cycles.
Foresite Capital is a multi-stage healthcare and life sciences investment firm addressing areas of great unmet need by funding promising businesses at all stages of their life cycles.
https://www.foresitecapital.com/
06 · Sources
Last verified: Oct 28, 2026